文献速递前列腺癌

保留Retzius间隙机器人辅助根治性前列腺切除术促进尿控早期恢复:随机对照单盲1年随访试验

Retzius-sparing robot-assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single-blind trial with a 1-year follow-up.
PubMed 文献 · BJU Int · 2020-08-17

该随机对照单盲试验将110例临床局限性前列腺癌患者按1:1随机分为前入路组和后入路(保留Retzius间隙)组,主要终点为拔除尿管后1周内即刻尿控。后入路组即刻尿控率69.1%显著高于前入路组30.9%(RR 2.24,95%CI 1.48-3.51;P=0.000),12个月随访尿控恢复亦更优(HR 1.51,95%CI 1.01-2.24;log-rank P=0.007),两组并发症、切缘阳性及生化复发无显著差异。

要点

  • 保留Retzius间隙后入路组即刻尿控率69.1%,前入路组30.9%,差异显著。
  • 12个月随访后入路组尿控恢复仍优于前入路组(HR 1.51,P=0.007)。
  • 高危亚组两组尿控恢复无显著差异(HR 1.26,P=0.415)。

核心结论

  • 保留Retzius间隙的后入路机器人辅助根治性前列腺切除术较传统前入路显著改善临床局限性前列腺癌患者的尿控早期恢复。

研究设计与样本

  • 前瞻性随机对照单盲试验,纳入110例临床局限性前列腺癌患者,按1:1随机分为前入路组(n=55)和后入路组(n=55)。

主要发现

  • 后入路组即刻尿控率为69.1%,前入路组为30.9%(RR 2.24,95%CI 1.48-3.51;P=0.000)。
  • 12个月随访期间,后入路组尿控恢复的Kaplan-Meier曲线优于前入路组(HR 1.51,95%CI 1.01-2.24;log-rank P=0.007)。
  • 两组并发症(P=0.399)、切缘阳性(P=0.225)及生化复发无进展生存(HR 4.80,95%CI 0.97-23.78;log-rank P=0.111)均无显著差异。
  • 高危前列腺癌亚组中,两种入路尿控恢复无显著差异(HR 1.26,95%CI 0.63-2.51;log-rank P=0.415)。

关键数值与推荐

  • 主要终点即刻尿控定义为拔除尿管后1周内不使用任何尿垫。

临床怎么用

  • 对于临床局限性前列腺癌,保留Retzius间隙的后入路机器人辅助根治性前列腺切除术可优先考虑以促进早期尿控恢复。
  • 高危患者选择后入路时需个体化评估,因该亚组尿控获益不显著。

局限性

  • 需进一步前瞻性研究确认保留Retzius间隙入路在临床局限性前列腺癌尤其是高危病例中的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of Retzius-sparing robot-assisted radical prostatectomy (posterior approach) on early recovery of urinary continence (UC) compared to the conventional approach (anterior approach) for the treatment of clinically localized prostate cancer (PCa). METHODS: A total of 110 consecutive patients with clinically localized PCa were prospectively randomized in a 1:1 ratio to an anterior group (n = 55) or a posterior group (n = 55). The primary outcome was immediate UC, defined as freedom from any pad use within 1 week after removal of the urinary catheter. The UC rate following surgery was also calculated with Kaplan-Meier curves, and the log-rank test was used for statistical comparison. Intra-operative outcomes, pathological data and oncological outcomes, including positive surgical margin (PSM) status and biochemical recurrence-free survival (BCRFS), were also compared between the two groups. The comparison of the two approaches was also analysed in subgroups after risk stratification. RESULTS: Of the patients who underwent the posterior approach, 69.1% achieved immediate UC compared with 30.9% in the anterior group (relative risk 2.24, 95% confidence interval [CI] 1.48-3.51; P = 0.000). The relative Kaplan-Meier curves for UC during the 12-month follow-up revealed statistically better recovery in the posterior group when compared with the anterior group (hazard ratio [HR] 1.51, 95% CI 1.01-2.24; log-rank P = 0.007). No statistically significant differences were observed between the groups regarding complications (P = 0.399), PSM status (P = 0.225) or BCRFS (HR 4.80, 95% CI 0.97-23.78; log-rank P = 0.111). In sub-analyses, no significant difference between the two approaches with regard to UC recovery in patients with high-risk PCa was observed (HR 1.26, 95% CI 0.63-2.51; log-rank P = 0.415). CONCLUSIONS: The Retzius-sparing approach significantly improved early recovery of UC compared to the conventional approach. Further prospective studies are needed to confirm the benefits of the Retzius-sparing approach for clinically localized PCa, especially for high-risk cases.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Qiu X, Li Y, Chen M, et al. Retzius-sparing robot-assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single-blind trial with a 1-year follow-up. BJU Int. 2020. PMID: 32741099. doi:10.1111/bju.15195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。